Detalhe da pesquisa
1.
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.
Lancet Glob Health
; 12(2): e282-e291, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142692
2.
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study.
medRxiv
; 2023 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461582
3.
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.
Open Forum Infect Dis
; 10(12): ofad583, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045558
4.
Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort study.
J Int AIDS Soc
; 26(9): e26164, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767825